Financial reports
ARS
2023 FY
Annual report to shareholders
19 Apr 24
10-K
2023 FY
Annual report
29 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
11 Apr 23
10-K
2022 FY
Annual report
17 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
29 Feb 24
8-K
Other Events
20 Feb 24
8-K
Karyopharm Announces Preliminary Unaudited 2023 Revenue and 2024 Objectives
8 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12 Dec 23
8-K
Departure of Directors or Certain Officers
8 Dec 23
8-K
Karyopharm Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
2 Nov 23
8-K
Departure of Directors or Certain Officers
1 Sep 23
8-K
Karyopharm Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
2 Aug 23
8-K
Departure of Directors or Certain Officers
25 May 23
8-K
Karyopharm Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
4 May 23
Registration and prospectus
SC TO-C
Information about tender offer
8 Apr 24
S-8
Registration of securities for employees
2 Aug 23
S-3
Shelf registration
17 Feb 23
S-8
Registration of securities for employees
17 Feb 23
S-3
Shelf registration
23 Dec 22
D
$165.00 mm in equity / options / securities to be acquired, sold $165.00 mm, 33 investors
8 Dec 22
S-8
Registration of securities for employees
3 Jun 22
S-8
Registration of securities for employees
28 Feb 22
S-8
Registration of securities for employees
5 Aug 21
S-3ASR
Automatic shelf registration
5 Aug 21
Proxies
DEFA14A
Additional proxy soliciting materials
19 Apr 24
DEF 14A
Definitive proxy
19 Apr 24
PRE 14A
Preliminary proxy
8 Apr 24
DEFA14A
Additional proxy soliciting materials
11 Apr 23
DEF 14A
Definitive proxy
11 Apr 23
PRE 14A
Preliminary proxy
31 Mar 23
DEFA14A
Additional proxy soliciting materials
12 May 22
DEFA14A
Additional proxy soliciting materials
8 Apr 22
DEF 14A
Definitive proxy
8 Apr 22
DEFA14A
Additional proxy soliciting materials
3 May 21
Other
EFFECT
Notice of effectiveness
8 May 23
CORRESP
Correspondence with SEC
3 May 23
UPLOAD
Letter from SEC
21 Feb 23
EFFECT
Notice of effectiveness
4 Jan 23
CORRESP
Correspondence with SEC
29 Dec 22
UPLOAD
Letter from SEC
28 Dec 22
CT ORDER
Confidential treatment order
13 Jul 21
CT ORDER
Confidential treatment order
19 Apr 21
EFFECT
Notice of effectiveness
25 Apr 19
CORRESP
Correspondence with SEC
22 Apr 19